Latest News

Drug Updates Articles

Filter by:
Topic
Clear filter
-positive non-small cell lung cancer
Drug Updates

Pharmacist’s Application to Practice: Repotrectinib

January 25, 2024

Christopher L. Cornett II, PharmD PGY1 Acute Care Pharmacy Resident Anne E Hitron, PharmD, MS, MBA, BCOP ,Oncology Pharmacy Specialist, Baptist Health Louisville, Louisville, Kentucky

Myelofibrosis with anemia
Drug Updates

Pharmacist's Application to Practice: Momelotinib

January 11, 2024

Diana Mansour, PharmD, BCOP, Clinical Pharmacy Specialist, Charles M Gallagher, PharmD, PGY2 Oncology Pharmacy Resident; Kelsea Seago, PharmD, BCOP, Clinical Pharmacy Specialist, allfrom WVUH Hospitals, write about Momelotinib.

uveal melanoma with unresectable hepatic metastases
Drug Updates

Pharmacist’s Application to Practice: Hepzato Kit™

January 11, 2024

Lainey Vargo, PharmD, PGY2-Oncology Resident Katie Murto, PharmD, BCOP and Crystal Heise, PharmD, BCOP WVUH Hospitals, Morgantown, West Virginia.

X-ray of brain with desmoid tumors
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Nirogacestat (Ogsiveo)

December 27, 2023

Brooke Lochridge, PharmD ,PGY-2 Oncology Pharmacy Resident, of Tristar Centennial Medical Center, Nashville, TN, and Colleen McCabe, PharmD, BCOP, Oncology Clinical Specialist, Sarcoma & Melanoma from Vanderbilt University Medical Center, Nashville, TN w

high-risk neuroblastoma
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Eflornithine for High-Risk Neuroblastoma

December 13, 2023

Taylor Gullickson, PharmD, PGY1 Pharmacy Resident and Alexis Kuhn, PharmD, BCOP, Pediatric Oncology Pharmacist, from Mayo Clinic Rochester, Minnesota write about Eflornithine for High-Risk Neuroblastoma.

close up photo of colon cancer cells
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Fruquintinib

December 08, 2023

Hunter Sowell, PharmD, PGY-2 Oncology Pharmacy Resident and Sarah Cimino, PharmD, BCOP, Clinical Pharmacist Specialist, Gastrointestinal Oncology, both from Vanderbilt University Medical Center, write about fruquintinib.

Woman pointing to x-ray of metastatic breast cancer diagram
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Capivasertib

November 26, 2023

Rachel B Allen, PharmD, PGY1 Pharmacy Resident and Sarah Cimino, PharmD, BCOP, Clinical Pharmacist Specialist, Gastrointestinal Oncology, both from Vanderbilt University Medical Center, write about Capivasertib.

Drug Updates

Pharmacist's Application to Practice: Glofitamab

November 06, 2023

Morgan Bizzell, PharmD and PGY2 Oncology Pharmacy Resident at UNC Medical Center writes about Glofitamab.

Acute Myeloid Leukemia under microscope
Drug Updates

Pharmacist's Application to Practice: Quizartinib

November 06, 2023

Eugene Lee, BS, PharmD, Medical Affairs Postdoctoral Fellow, UNC/GSK and Amber Cipriani, PharmD, BCOP, Precision Medicine Pharmacy Coordinator at UNC Health Medical Center write about Quizartinib.

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Retifanlimab-dlwr

March 22, 2023

Bernard Marini, PharmD, BCOP, Clinical Pharmacist Specialist at University of Michigan College of Pharmacy writes about Retifanlimab-dlwr.

Drug Updates

Pharmacist’s Application to Practice: Elacestrant

January 27, 2023

Monica Chintapenta, PharmD, BCOP, Pharmacist Clinical Specialist at Parkland Health and Hospital Systems writes about Elacestrant

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Pirtobrutinib

January 27, 2023

Andy Hawn, 2025 PharmD Candidate and Erin Kelley, PharmD, BCOP at the Masonic Cancer Clinic Infusion Pharmacy write about Pirtobrutinib